Drug name - Tybost
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8148374 | GILEAD SCIENCES INC | Modulators of pharmacokinetic properties of therapeutics |
Sep, 2029
(6 years from now) | |
| CN101796040A | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2013
(9 years ago) | |
| CN101679325B | GILEAD SCIENCES INC | Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent |
Jul, 2027
(4 years from now) | |
| CN103275033A | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2027
(4 years from now) | |
| CN103435570A | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2027
(4 years from now) | |
| CN101490023B | GILEAD SCIENCES INC | Chinese Medicine Dynamics Characteristic Regulator Therapeutic Agent |
Jul, 2027
(4 years from now) | |
| CN101490023A | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2027
(4 years from now) | |
| CN103275033B | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2027
(4 years from now) | |
| CN103435570B | GILEAD SCIENCES INC | Pharmacokinetics Character Regulator Of Therapeutic Agent |
Jul, 2027
(4 years from now) | |
| CN101679325A | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2027
(4 years from now) | |
| IN332719B | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2028
(5 years from now) | |
| IN200810487P1 | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2028
(5 years from now) | |
| EP3112355A1 | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2027
(4 years from now) | |
| EP2487165B1 | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2027
(4 years from now) | |
| EP2487165A1 | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2027
(4 years from now) | |
| EP3112355B1 | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2027
(4 years from now) | |
| EP2049506A2 | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2027
(4 years from now) | |
| EP2049506B1 | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2027
(4 years from now) | |
| EP2049506B9 | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2027
(4 years from now) | |
| EP2487161B1 | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2028
(5 years from now) | |
| EP2118082A1 | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2028
(5 years from now) | |
| EP2118082B1 | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2028
(5 years from now) | |
| EP2487161A1 | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2028
(5 years from now) | |
| EP3150586B1 | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2028
(5 years from now) | |
| EP3150586A1 | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2028
(5 years from now) | |
| EP2487166A1 | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2028
(5 years from now) | |
| EP2487166B1 | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2028
(5 years from now) | |
| EP2487162A1 | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2028
(5 years from now) | |
| EP2487162B1 | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Feb, 2028
(5 years from now) | |
| EP2487163A1 | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Mar, 2028
(5 years from now) | |
| EP2487163B1 | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Mar, 2028
(5 years from now) | |
| EP2170851B1 | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2028
(5 years from now) | |
| EP2170851A1 | GILEAD SCIENCES INC | Modulators Of Pharmacokinetic Properties Of Therapeutics |
Jul, 2028
(5 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US8148374
(Pediatric) | GILEAD SCIENCES INC | Modulators of pharmacokinetic properties of therapeutics |
Mar, 2030
(7 years from now) | |
| US10039718 | GILEAD SCIENCES INC | Use of solid carrier particles to improve the processability of a pharmaceutical agent |
Oct, 2032
(10 years from now) | |
|
US10039718
(Pediatric) | GILEAD SCIENCES INC | Use of solid carrier particles to improve the processability of a pharmaceutical agent |
Apr, 2033
(10 years from now) | |
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 150MG | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.